As of Q4'25, VRT reported SG&A Expenses of USD 462M, while R&D Expenses remained at USD 0. This marks the highest SG&A expense level in the period observed, with no allocation to R&D throughout. From Q1'23 to Q4'25, SG&A Expenses for VRT showed an overall upward trend, rising from USD 309M to USD 462M. The data reveals periods of both moderate growth and sharper increases, particularly notable in the last two quarters of 2025. R&D Expenses consistently remained at zero, indicating no reported investment in research and development during this timeframe.